You are here
AdvaMed Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement today from President and CEO Scott Whitaker regarding Senate confirmation of FDA Commissioner Dr. Scott Gottlieb:
“On behalf of AdvaMed, I’d like to congratulate Dr. Gottlieb on his confirmation as FDA Commissioner. His previous experience at FDA as well as his time at CMS make him uniquely qualified to lead this vital agency.
“Dr. Gottlieb recognizes the crucial role of medical technology in solving some of our nation’s most daunting health care challenges and the importance of a strong, efficient and predictable FDA in ensuring continued patient access to safe and effective medical innovations.
“We look forward to working with Commissioner Gottlieb and his team on efforts to improve the FDA review process as well as reauthorization of the Medical Device User Fee Act (MDUFA) and implementation of the 21st Century Cures Act.”